1
|
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
|
N Engl J Med
|
2011
|
10.79
|
2
|
Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.
|
N Engl J Med
|
2010
|
8.51
|
3
|
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
|
N Engl J Med
|
2012
|
6.64
|
4
|
Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial.
|
Lancet
|
2012
|
2.69
|
5
|
HIV partner notification is effective and feasible in sub-Saharan Africa: opportunities for HIV treatment and prevention.
|
J Acquir Immune Defic Syndr
|
2011
|
2.49
|
6
|
Prevention of mother-to-child transmission: program changes and the effect on uptake of the HIVNET 012 regimen in Malawi.
|
AIDS
|
2008
|
2.48
|
7
|
Concurrent sexual partnerships among African Americans in the rural south.
|
Ann Epidemiol
|
2004
|
2.47
|
8
|
Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi.
|
Contemp Clin Trials
|
2008
|
2.35
|
9
|
The prevention of mother-to-child HIV transmission programme in Lilongwe, Malawi: why do so many women drop out.
|
Reprod Health Matters
|
2009
|
2.04
|
10
|
The health of HIV-exposed children after early weaning.
|
Matern Child Nutr
|
2011
|
2.01
|
11
|
HIV incidence among women of reproductive age in Malawi and Zimbabwe.
|
Sex Transm Dis
|
2006
|
1.75
|
12
|
Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial.
|
Sex Transm Dis
|
2003
|
1.52
|
13
|
Potential initiators of HIV-related stigmatization: ethical and programmatic challenges for PMTCT programs.
|
Dev World Bioeth
|
2008
|
1.46
|
14
|
The HPTN 024 Study: the efficacy of antibiotics to prevent chorioamnionitis and preterm birth.
|
Am J Obstet Gynecol
|
2006
|
1.37
|
15
|
Validation of a urine-based PCR-enzyme-linked immunosorbent assay for use in clinical research settings to detect Trichomonas vaginalis in men.
|
J Clin Microbiol
|
2003
|
1.34
|
16
|
Use of massively parallel pyrosequencing to evaluate the diversity of and selection on Plasmodium falciparum csp T-cell epitopes in Lilongwe, Malawi.
|
J Infect Dis
|
2012
|
1.21
|
17
|
Preventive misconception as a motivation for participation and adherence in microbicide trials: evidence from female participants and male partners in Malawi and Zimbabwe.
|
AIDS Behav
|
2012
|
1.12
|
18
|
Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007.
|
Sex Transm Dis
|
2010
|
1.11
|
19
|
Predictors of stillbirth in sub-saharan Africa.
|
Obstet Gynecol
|
2007
|
1.10
|
20
|
Evaluating nurses' implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, Malawi.
|
AIDS Educ Prev
|
2009
|
1.07
|
21
|
HIV and parasitic infection and the effect of treatment among adult outpatients in Malawi.
|
J Infect Dis
|
2007
|
1.05
|
22
|
Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study.
|
J Clin Virol
|
2012
|
1.02
|
23
|
HPTN 024 study: histologic chorioamnionitis, antibiotics and adverse infant outcomes in a predominantly HIV-1-infected African population.
|
Am J Obstet Gynecol
|
2006
|
1.00
|
24
|
Impact of aciclovir on ulcer healing, lesional, genital and plasma HIV-1 RNA among patients with genital ulcer disease in Malawi.
|
Sex Transm Infect
|
2010
|
0.99
|
25
|
Assessment of peer-based and structural strategies for increasing male participation in an antenatal setting in Lilongwe, Malawi.
|
Afr J Reprod Health
|
2014
|
0.92
|
26
|
Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa.
|
Pediatrics
|
2009
|
0.92
|
27
|
The acceptance and feasibility of replacement feeding at 6 months as an HIV prevention method in Lilongwe, Malawi: results from the BAN study.
|
AIDS Educ Prev
|
2011
|
0.91
|
28
|
The use of specimens from various genitourinary sites in men, to detect Trichomonas vaginalis infection.
|
J Infect Dis
|
2004
|
0.90
|
29
|
STI patients are effective recruiters of undiagnosed cases of HIV: results of a social contact recruitment study in Malawi.
|
J Acquir Immune Defic Syndr
|
2014
|
0.89
|
30
|
Bacterial infections in Lilongwe, Malawi: aetiology and antibiotic resistance.
|
BMC Infect Dis
|
2012
|
0.88
|
31
|
Comparative population structure of Plasmodium falciparum circumsporozoite protein NANP repeat lengths in Lilongwe, Malawi.
|
Sci Rep
|
2013
|
0.88
|
32
|
Predicting partner HIV testing and counseling following a partner notification intervention.
|
AIDS Behav
|
2012
|
0.87
|
33
|
Viral response to chemotherapy in endemic burkitt lymphoma.
|
Clin Cancer Res
|
2010
|
0.87
|
34
|
Exploring the feasibility of engaging Traditional Birth Attendants in a prevention of mother to child HIV transmission program in Lilongwe, Malawi.
|
Malawi Med J
|
2012
|
0.86
|
35
|
HPTN 062: a feasibility and acceptability pilot intervention to reduce HIV transmission risk behaviors among individuals with acute and early HIV infection in Lilongwe, Malawi.
|
AIDS Behav
|
2014
|
0.86
|
36
|
Evaluating the benefits of incorporating traditional birth attendants in HIV prevention of mother to child transmission service delivery in Lilongwe, Malawi.
|
Afr J Reprod Health
|
2014
|
0.85
|
37
|
Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN Study.
|
Antivir Ther
|
2014
|
0.84
|
38
|
Etiology of genital ulcer disease and association with HIV infection in Malawi.
|
Sex Transm Dis
|
2013
|
0.84
|
39
|
Effect of prenatal and perinatal antibiotics on maternal health in Malawi, Tanzania, and Zambia.
|
Int J Gynaecol Obstet
|
2009
|
0.83
|
40
|
Diversity of T cell epitopes in Plasmodium falciparum circumsporozoite protein likely due to protein-protein interactions.
|
PLoS One
|
2013
|
0.83
|
41
|
Factors influencing utilization of postpartum CD4 count testing by HIV-positive women not yet eligible for antiretroviral treatment.
|
AIDS Care
|
2011
|
0.78
|